Joshua Morris, OD
Optometrist · Canal Winchester, OHNPI 1982261202
Payments from drug & device makers
Across 104 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$331
- Alcon$200
- Mallinckrodt Hospital Products Inc.$174
- Oyster Point Pharma, Inc.$169
- Sun Pharmaceutical Industries Inc.$153
- Tarsus Pharmaceuticals, Inc.$152
- plus $968 from 16 others
What the payments were for
- Food & beverage$2,05496%
- Education$934%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $331 |
| Alcon | 9 | $200 |
| Mallinckrodt Hospital Products Inc. | 5 | $174 |
| Oyster Point Pharma, Inc. | 9 | $169 |
| Sun Pharmaceutical Industries Inc. | 8 | $153 |
| Tarsus Pharmaceuticals, Inc. | 6 | $152 |
| Kala Pharmaceuticals, Inc. | 9 | $148 |
| Amgen(2 entities) | 7 | $122 |
| Novartis | 4 | $111 |
| Aerie Pharmaceuticals, Inc. | 5 | $95 |
| Bausch & Lomb Americas Inc. | 4 | $88 |
| Biotissue Holdings Inc. | 3 | $73 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $58 |
| Glaukos Corporation | 2 | $55 |
| Dompe US, Inc. | 2 | $40 |
| Rayner Intraocular Lenses Limited | 2 | $37 |
| Thea Pharma Inc. | 2 | $34 |
| Harrow Eye, LLC | 2 | $27 |
| Coopervision Inc. | 1 | $25 |
| Rxsight Inc | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $14 |
How this compares
$2,147 in reported general payments places this provider in the 75th percentile of 1,995 optometrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 49 | $1,825 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 101 | $1,117 |
| Latanoprost | 101 | $813 |
| Prednisolone Acetate | 25 | $442 |
| Doxycycline Monohydrate | 12 | $395 |
| ErythromycinErythromycin Base | 26 | $214 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $157 |
| Timolol Maleate | 22 | $116 |
| Cephalexin | 26 | $108 |
| Triamcinolone Acetonide | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Canal Winchester
- Katherine BickleGranville$3M
- Jennifer FogtColumbus$1.9M
- Jason MillerPowell$1.4M
- Mile BrujicBowling Green$1.3M
- William LayWesterville$891K
- Gregory DenaeyerColumbus$846K
- Thomas ChesterCleveland$786K
- Loretta Szczotka-FlynnCleveland$388K
- Cory LappinMontgomery$367K
- Dustin GardnerMarysville$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.